Overview
What is Oklahoma Society Of Clinical Oncology I?
The Oklahoma Society of Clinical Oncology I (OSCO) is a nonprofit organization based in Oklahoma City, Oklahoma. Its primary mission is to advance the sciences of hematology and oncology, along with its subspecialties, and improve services to the public. OSCO achieves this by studying the socioeconomic aspects of its members' practices. They conduct educational seminars, such as the ASCO Direct conference in November 2022, focusing on the latest research and strategies in oncology. In March 2023, they organized an in-person SABCS conference, presenting topics from the "Best of San Antonio Breast Cancer Symposium." These events provide healthcare professionals with up-to-date information on breast cancer and premalignant diseases.
Official website here: www.oscook.org
Is Oklahoma Society Of Clinical Oncology I legitimate?
Oklahoma Society Of Clinical Oncology I is a legitimate nonprofit organization registered as a 501(c)(6) entity. Oklahoma Society Of Clinical Oncology I submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $62,000
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.oscook.org
What is the mission statement of Oklahoma Society Of Clinical Oncology I?
The Oklahoma Society of Clinical Oncology I (OSCO) is committed to enhancing services, fostering education, and advancing the sciences in the field of hematology and oncology, along with its subspecialties. Their mission is to further the sciences of hematology and oncology by studying the socioeconomic aspects of its members' practices, ultimately improving services for the public.
In pursuit of this mission, OSCO conducts educational seminars, such as the ASCO Direct conference in November 2022, showcasing the latest research and strategies in oncology. Additionally, OSCO organized an in-person SABCS conference in March 2023, focusing on the latest developments in breast cancer research and treatment, drawing from the "Best of San Antonio Breast Cancer Symposium" held in December 2022. These seminars aim to provide healthcare professionals in medical, surgical, gynecologic, and radiation oncology with up-to-date information on breast cancer and premalignant breast diseases.
Official website here: www.oscook.org
Who is the CEO of Oklahoma Society Of Clinical Oncology I?
Jose Eugenio Najera Md is the Board Member of Oklahoma Society Of Clinical Oncology I.
Official website here: www.oscook.org
What is the revenue of Oklahoma Society Of Clinical Oncology I?
Oklahoma Society Of Clinical Oncology I's revenue in 2023 was $178,124.
Official website here: www.oscook.org
Who are the executives of Oklahoma Society Of Clinical Oncology I and what are their salaries?
There 8 volunteers at Oklahoma Society Of Clinical Oncology I.
Here are 9 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $62,000
- Related: $0
- Other: $0
Official website here: www.oscook.org
Where can I find the form 990 for Oklahoma Society Of Clinical Oncology I?
Oklahoma Society Of Clinical Oncology I's most recent form 990 was submitted in 2023 and can be accessed here.
Official website here: www.oscook.org
Learn more at the official website: www.oscook.org
Mission Statement of Oklahoma Society Of Clinical Oncology I
The Oklahoma Society of Clinical Oncology I, a respected organization in the field of hematology and oncology, is dedicated to advancing the sciences in these areas and improving services for the public. Their primary objective is to study the socioeconomic aspects of their members' practices to enhance their contributions to society. The Society aims to achieve this mission by promoting education and fostering research in hematology and oncology, as well as its subspecialties.
In line with this mission, the Oklahoma Society of Clinical Oncology I conducts educational seminars to share the latest advancements in oncology. For instance, on November 12, 2022, they held an in-person conference called ASCO Direct, which focused on the most significant research and strategies in oncology presented at the 2022 Virtual American Society of Clinical Oncology (ASCO) Annual Meeting and other national oncology meetings. Moreover, on March 25, 2023, they organized an in-person SABCS conference, covering topics from the "Best of San Antonio Breast Cancer Symposium" held in December 2022. This seminar provided cutting-edge information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, targeting healthcare professionals involved in breast cancer in medical, surgical, gynecologic, and radiation oncology.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Oklahoma Society of Clinical Oncology I (OSCO) significantly enhances the field of hematology and oncology through education, research dissemination, and community engagement. By organizing conferences such as the ASCO Direct and the SABCS conference, OSCO ensures that healthcare professionals in Oklahoma stay updated on cutting-edge research and treatment strategies.
These events focus on critical topics, including the latest advancements in breast cancer, experimental biology, and clinical practices. Gathering experts to discuss findings from major national events allows practitioners to integrate new knowledge into their practices, ultimately leading to improved patient care.
Additionally, OSCO's commitment to studying the socioeconomic aspects of oncology helps identify and address barriers to access and quality of care. This holistic approach not only advances the science but also aims to improve services for the community, providing healthcare professionals with the tools they need to make informed decisions and positively impact patient outcomes. Overall, OSCO plays a vital role in fostering a collaborative environment that prioritizes continuous learning and improvement in oncology practices across Oklahoma.
This information is meant to be a general summary of Oklahoma Society Of Clinical Oncology I. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Investment Income: -$5,610
- Program Service Revenue: $55,234
- Gross Receipts: $256,984
Assets and Liabilities:
- Total Assets: $554,719
- Total Liabilities: $0
- Net Assets: $554,719
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
EXHIBITOR FEES
Revenue
$54,800
REGISTRATION FEES
Revenue
$434
Organization Details
Founding Year
1985
Phone
(405) 850-8334Principal Officer
Jose Eugenio Najera Md
Main Address
PO BOX 720024, OKLAHOMA CITY, OK, 73172
Website
www.oscook.orgNTEE Category
Code: S41 - Community improvement
If you are a representative of Oklahoma Society Of Clinical Oncology I and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.